NYSE · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · LARGE CAP
Teladoc Health, Inc. TDOC
13 fiscal years on record · USD · FY2025 reported · SEC filings only
Growth
USD 2.5B
Revenue, FY2025 · full 13-year series below
Revenue $B
Net income $B
FY2025 · Revenue 2.5 · Net income -0.2
Compound annual growth
Revenue compounded at +18.3% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−8 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -10.4% · Net -7.9%
ROE
FY2025 · ROE -13.9%
Each USD of equity lost 14 cents this year.
The 13-year record
13 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 2.5 | 2.6 | 2.6 | 2.4 | 2.0 | 1.1 | 0.6 | 0.4 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 |
| Operating income $B | −0.3 | −1.0 | −0.2 | −13.7 | −0.3 | −0.5 | −0.1 | −0.1 | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 |
| EBITDA $B | · | · | · | −13.4 | −0.1 | −0.4 | −0.0 | −0.0 | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 |
| Income tax $B | −0.0 | 0.0 | 0.0 | −0.0 | 0.0 | −0.1 | −0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.2 | −1.0 | −0.2 | −13.7 | −0.4 | −0.5 | −0.1 | −0.1 | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 |
| Free cash flow $B | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | −0.1 | 0.0 | −0.0 | −0.0 | −0.1 | −0.1 | −0.0 | −0.0 |
| EPS, diluted $ | −1.14 | −5.87 | −1.34 | −84.60 | −2.73 | −5.36 | −1.38 | −1.47 | −1.93 | −1.75 | −2.91 | −10.25 | −8.05 |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · | · | · | · |
| ROE % | −13.9 | −52.5 | −9.5 | −148.8 | −2.7 | −5.7 | −9.8 | −12.4 | −27.0 | −36.3 | −104.5 | · | · |
| Shares out B | 0.18 | 0.17 | 0.17 | 0.16 | 0.16 | 0.15 | 0.07 | 0.07 | 0.06 | 0.05 | 0.04 | 0.00 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 56 reconciliationsAUDITED
Reconciled in 13 of 19 fiscal years. 37 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Offices & Clinics of Doctors of Medicine
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2013